Healthcare -
Biotechnology - NASDAQ - US
$ 2.68
0 %
$ 77.7 M
Market Cap
-0.05
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Aerovate Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 74.6 M |
| Operating Income | -74.6 M |
| Other Expenses | -4.97 M |
| Net Income | -69.6 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 96 K | 68 K | 15 K | 1 K | 0 |
| Gross Profit | 0 | 96 K | 68 K | 15 K | 1 K | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 74.6 | 81.4 | 53.2 | 23.0 | 8.9 | 3.3 |
| Selling, General and Administrative Expenses | 21.4 | 17.2 | 14.6 | 8.0 | 0.9 | 0.2 |
| Research and Development Expenses | 53.2 | 64.2 | 38.6 | 15.0 | 7.9 | 3.1 |
| Operating Income | (74.6) | (81.4) | (53.2) | (23.0) | (8.9) | (3.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 65 K | 75 K | 0 |
| Total Other Income | 5.0 | 5.9 | 1.8 | 62 K | (0.7) | 2 K |
| Pre-Tax Income | (69.6) | (75.5) | (51.5) | (23.0) | (9.6) | (3.3) |
| NET INCOME | ||||||
| Tax Provision | 55 K | 56 K | 25 K | 3 K | (0.6) | 1 K |
| Net Income | (69.6) | (75.5) | (51.5) | (23.0) | (9.0) | (3.3) |
| EPS | 2.44 | 2.87 | 2.1 | 0.94 | 0.37 | 0.14 |